287 related articles for article (PubMed ID: 25910501)
1. Clinical impact of gastrointestinal bleeding in patients undergoing percutaneous coronary interventions.
Koskinas KC; Räber L; Zanchin T; Wenaweser P; Stortecky S; Moschovitis A; Khattab AA; Pilgrim T; Blöchlinger S; Moro C; Jüni P; Meier B; Heg D; Windecker S
Circ Cardiovasc Interv; 2015 May; 8(5):. PubMed ID: 25910501
[TBL] [Abstract][Full Text] [Related]
2. Duration of Triple Antithrombotic Therapy and Outcomes Among Patients Undergoing Percutaneous Coronary Intervention.
Koskinas KC; Räber L; Zanchin T; Pilgrim T; Stortecky S; Hunziker L; Blöchlinger S; Billinger M; Gartwyl F; Moro C; Moschovitis A; Jüni P; Heg D; Windecker S
JACC Cardiovasc Interv; 2016 Jul; 9(14):1473-83. PubMed ID: 27478115
[TBL] [Abstract][Full Text] [Related]
3. Adjunctive cilostazol versus double-dose clopidogrel after drug-eluting stent implantation: the HOST-ASSURE randomized trial (Harmonizing Optimal Strategy for Treatment of Coronary Artery Stenosis-Safety & Effectiveness of Drug-Eluting Stents & Anti-platelet Regimen).
Park KW; Kang SH; Park JJ; Yang HM; Kang HJ; Koo BK; Park BE; Cha KS; Rhew JY; Jeon HK; Shin ES; Oh JH; Jeong MH; Kim S; Hwang KK; Yoon JH; Lee SY; Park TH; Moon KW; Kwon HM; Chae IH; Kim HS
JACC Cardiovasc Interv; 2013 Sep; 6(9):932-42. PubMed ID: 24050860
[TBL] [Abstract][Full Text] [Related]
4. Impact of in-hospital bleeding according to the Bleeding Academic Research Consortium classification on the long-term adverse outcomes in patients undergoing percutaneous coronary intervention.
Yoon YH; Kim YH; Kim SO; Lee JY; Park DW; Kang SJ; Lee SW; Lee CW; Park SW; Park SJ
Catheter Cardiovasc Interv; 2015 Jan; 85(1):63-71. PubMed ID: 24282105
[TBL] [Abstract][Full Text] [Related]
5. Incidence, Predictors, and Impact of Post-Discharge Bleeding After Percutaneous Coronary Intervention.
Généreux P; Giustino G; Witzenbichler B; Weisz G; Stuckey TD; Rinaldi MJ; Neumann FJ; Metzger DC; Henry TD; Cox DA; Duffy PL; Mazzaferri E; Yadav M; Francese DP; Palmerini T; Kirtane AJ; Litherland C; Mehran R; Stone GW
J Am Coll Cardiol; 2015 Sep; 66(9):1036-45. PubMed ID: 26314532
[TBL] [Abstract][Full Text] [Related]
6. Prognostic implications of bleeding measured by Bleeding Academic Research Consortium (BARC) categorisation in patients undergoing primary percutaneous coronary intervention.
Matic DM; Milasinovic DG; Asanin MR; Mrdovic IB; Marinkovic JM; Kocev NI; Marjanovic MM; Antonijevic NM; Vukcevic VD; Savic LZ; Zivkovic MN; Mehmedbegovic ZH; Dedovic VM; Stankovic GR
Heart; 2014 Jan; 100(2):146-52. PubMed ID: 24179161
[TBL] [Abstract][Full Text] [Related]
7. Correlates and consequences of gastrointestinal bleeding complicating percutaneous coronary intervention.
Gaglia MA; Torguson R; Gonzalez MA; Ben-Dor I; Maluenda G; Collins SD; Syed AI; Delhaye C; Wakabayashi K; Belle L; Mahmoudi M; Hanna N; Xue Z; Kaneshige K; Suddath WO; Kent KM; Satler LF; Pichard AD; Waksman R
Am J Cardiol; 2010 Oct; 106(8):1069-74. PubMed ID: 20920640
[TBL] [Abstract][Full Text] [Related]
8. Perioperative management of oral antiplatelet therapy and clinical outcomes in coronary stent patients undergoing surgery. Results of a multicentre registry.
Rossini R; Musumeci G; Capodanno D; Lettieri C; Limbruno U; Tarantini G; Russo N; Calabria P; Romano M; Inashvili A; Sirbu V; Guagliumi G; Valsecchi O; Senni M; Gavazzi A; Angiolillo DJ
Thromb Haemost; 2015 Feb; 113(2):272-82. PubMed ID: 25274620
[TBL] [Abstract][Full Text] [Related]
9. Prognostic implications of early and long-term bleeding events in patients on one-year dual antiplatelet therapy following drug-eluting stent implantation.
Musumeci G; Rossini R; Lettieri C; Capodanno D; Romano M; Rosiello R; Guagliumi G; Valsecchi O; Gavazzi A; Angiolillo DJ
Catheter Cardiovasc Interv; 2012 Sep; 80(3):395-405. PubMed ID: 22109961
[TBL] [Abstract][Full Text] [Related]
10. Prognostic impact of periprocedural bleeding and myocardial infarction after percutaneous coronary intervention in unselected patients: results from the EVENT (evaluation of drug-eluting stents and ischemic events) registry.
Lindsey JB; Marso SP; Pencina M; Stolker JM; Kennedy KF; Rihal C; Barsness G; Piana RN; Goldberg SL; Cutlip DE; Kleiman NS; Cohen DJ;
JACC Cardiovasc Interv; 2009 Nov; 2(11):1074-82. PubMed ID: 19926047
[TBL] [Abstract][Full Text] [Related]
11. Real clinical experiences of dual versus triple antithrombotic therapy after percutaneous coronary intervention.
Wustrow I; Sarafoff N; Haller B; Rössner L; Sibbing D; Schüpke S; Ibrahim T; Anetsberger A; Schunkert H; Laugwitz KL; Kastrati A; Bernlochner I
Catheter Cardiovasc Interv; 2018 Dec; 92(7):1239-1246. PubMed ID: 30019824
[TBL] [Abstract][Full Text] [Related]
12. Platelet reactivity and clinical outcomes after coronary artery implantation of drug-eluting stents (ADAPT-DES): a prospective multicentre registry study.
Stone GW; Witzenbichler B; Weisz G; Rinaldi MJ; Neumann FJ; Metzger DC; Henry TD; Cox DA; Duffy PL; Mazzaferri E; Gurbel PA; Xu K; Parise H; Kirtane AJ; Brodie BR; Mehran R; Stuckey TD;
Lancet; 2013 Aug; 382(9892):614-23. PubMed ID: 23890998
[TBL] [Abstract][Full Text] [Related]
13. Triple versus dual antiplatelet therapy in patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
Chen KY; Rha SW; Li YJ; Poddar KL; Jin Z; Minami Y; Wang L; Kim EJ; Park CG; Seo HS; Oh DJ; Jeong MH; Ahn YK; Hong TJ; Kim YJ; Hur SH; Seong IW; Chae JK; Cho MC; Bae JH; Choi DH; Jang YS; Chae IH; Kim CJ; Yoon JH; Chung WS; Seung KB; Park SJ;
Circulation; 2009 Jun; 119(25):3207-14. PubMed ID: 19528339
[TBL] [Abstract][Full Text] [Related]
14. Clinical implications of very low on-treatment platelet reactivity in patients treated with thienopyridine: the POBA study (predictor of bleedings with antiplatelet drugs).
Cuisset T; Grosdidier C; Loundou AD; Quilici J; Loosveld M; Camoin L; Pankert M; Beguin S; Lambert M; Morange PE; Bonnet JL; Alessi MC
JACC Cardiovasc Interv; 2013 Aug; 6(8):854-63. PubMed ID: 23968703
[TBL] [Abstract][Full Text] [Related]
15. Predictors and consequences of postdischarge gastrointestinal bleeding after percutaneous coronary intervention.
Zhu P; Tang X; Xu J; Song Y; Liu R; Zhang Y; Gao L; Gao Z; Chen J; Yang Y; Gao R; Xu B; Yuan J
Cardiovasc Ther; 2018 Oct; 36(5):e12440. PubMed ID: 29863803
[TBL] [Abstract][Full Text] [Related]
16. Prevalence and impact of high platelet reactivity in chronic kidney disease: results from the Assessment of Dual Antiplatelet Therapy with Drug-Eluting Stents registry.
Baber U; Mehran R; Kirtane AJ; Gurbel PA; Christodoulidis G; Maehara A; Witzenbichler B; Weisz G; Rinaldi MJ; Metzger DC; Henry TD; Cox DA; Duffy PL; Mazzaferri EL; Xu K; Parise H; Brodie BR; Stuckey TD; Stone GW
Circ Cardiovasc Interv; 2015 Jun; 8(6):e001683. PubMed ID: 26056248
[TBL] [Abstract][Full Text] [Related]
17. Preprocedural High-Sensitivity Cardiac Troponin T and Clinical Outcomes in Patients With Stable Coronary Artery Disease Undergoing Elective Percutaneous Coronary Intervention.
Zanchin T; Räber L; Koskinas KC; Piccolo R; Jüni P; Pilgrim T; Stortecky S; Khattab AA; Wenaweser P; Bloechlinger S; Moschovitis A; Frenk A; Moro C; Meier B; Fiedler GM; Heg D; Windecker S
Circ Cardiovasc Interv; 2016 Jun; 9(6):. PubMed ID: 27296200
[TBL] [Abstract][Full Text] [Related]
18. Impact of clinical presentation on ischaemic and bleeding outcomes in patients receiving 6- or 24-month duration of dual-antiplatelet therapy after stent implantation: a pre-specified analysis from the PRODIGY (Prolonging Dual-Antiplatelet Treatment After Grading Stent-Induced Intimal Hyperplasia) trial.
Costa F; Vranckx P; Leonardi S; Moscarella E; Ando G; Calabro P; Oreto G; Zijlstra F; Valgimigli M
Eur Heart J; 2015 May; 36(20):1242-51. PubMed ID: 25718355
[TBL] [Abstract][Full Text] [Related]
19. Triple antithrombotic therapy is the independent predictor for the occurrence of major bleeding complications: analysis of percent time in therapeutic range.
Naruse Y; Sato A; Hoshi T; Takeyasu N; Kakefuda Y; Ishibashi M; Misaki M; Abe D; Aonuma K;
Circ Cardiovasc Interv; 2013 Aug; 6(4):444-51. PubMed ID: 23941857
[TBL] [Abstract][Full Text] [Related]
20. High on-treatment platelet reactivity as a risk factor for secondary prevention after coronary stent revascularization: A landmark analysis of the ARCTIC study.
Montalescot G; Rangé G; Silvain J; Bonnet JL; Boueri Z; Barthélémy O; Cayla G; Belle L; Van Belle E; Cuisset T; Elhadad S; Pouillot C; Henry P; Motreff P; Carrié D; Rousseau H; Aubry P; Monségu J; Sabouret P; O'Connor SA; Abtan J; Kerneis M; Saint-Etienne C; Beygui F; Vicaut E; Collet JP;
Circulation; 2014 May; 129(21):2136-43. PubMed ID: 24718568
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
